Day 5 IR vs OUT | P-value | Significant* | Total** |
Cholesterol Biosynthesis | 5.574E-13 | 15 | 21 |
Oxidative phosphorylation | 0.00002 | 21 | 99 |
Vitamin B6 metabolism | 0.00412 | 3 | 5 |
Cell adhesion_Gap junctions | 0.00536 | 6 | 22 |
Regulation of lipid metabolism_Insulin regulation of fatty acid methabolism | 0.00770 | 9 | 46 |
Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP | 0.00820 | 7 | 31 |
Cytoskeleton remodeling_Neurofilaments | 0.01043 | 6 | 25 |
Ubiquinone metabolism | 0.01169 | 9 | 49 |
Immune response_Antigen presentation by MHC class I | 0.0127 | 6 | 26 |
Cell adhesion_Endothelial cell contacts by junctional mechanisms | 0.0127 | 6 | 26 |
Day 28 IR vs OUT | P -value | Significant* | Total** |
Cholesterol Biosynthesis | 0.00000 | 10 | 21 |
Immune response_Antigen presentation by MHC class I | 0.00001 | 10 | 26 |
Immune response_Classic complement pathway | 0.00003 | 12 | 40 |
Immune response_IFN alpha/beta signalling pathway | 0.00005 | 9 | 24 |
Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP | 0.00209 | 8 | 31 |
Immune response_Antiviral actions of Interferons | 0.00209 | 8 | 31 |
CFTR folding and maturation (norm and CF) | 0.00320 | 5 | 14 |
Immune response_IL-22 signalling pathway | 0.00321 | 8 | 33 |
Neurodisease_Parkin disorder under Parkinson's disease | 0.00592 | 7 | 29 |
Immune response_Antigen presentation by MHC class II | 0.00790 | 4 | 11 |
Day 56 IR vs OUT | P -value | Significant* | Total** |
Immune response_NFAT in immune response | 0.00027 | 15 | 42 |
Immune response_Bacterial infections in normal airways | 0.00040 | 14 | 39 |
Bacterial infections in CF airways | 0.00048 | 15 | 44 |
Immune response_IL-12-induced IFN-gamma production | 0.00066 | 12 | 32 |
Immune response_ICOS pathway in T-helper cell | 0.00082 | 13 | 37 |
Immune response_CD28 signalling | 0.00123 | 14 | 43 |
Cell adhesion_Integrin-mediated cell adhesion and migration | 0.00201 | 14 | 45 |
Development_Angiopoietin - Tie2 signalling | 0.00250 | 11 | 32 |
Apoptosis and survival_HTR1A signalling | 0.00362 | 12 | 38 |
Sphingolipid metabolism/Human version | 0.00362 | 12 | 38 |